title: The Runme Shaw Memorial Lecture--transplantation of the heart and heart-lungs.
abstract: After ten years of experimental background, the first heart transplant at Stanford was performed on January 6, 1968. Six hundred and sixty-six patients have undergone 721 heart transplants since that date with an age range from five days to 64 years. The most common diagnosis has been cardiomyopathy with advanced coronary artery disease second. Current one and five year survival statistics are 81% and 60% respectively, with no difference in survival between the pediatric age group and adults. Percutaneous transvenous endomyocardial biopsy provides the gold standard for interpreting allograft rejection. At Stanford, 90 patients have undergone 91 heart-lung transplants since the first successful case in 1981. Twelve patients with cystic fibrosis have been transplanted and four of these recipients have been heart donors, the domino donor principle. Two double lung transplants have been performed utilising separate bronchial anastomoses. Fourteen patients have undergone 15 single lung transplants and three of these have been patients with the Eisenmenger syndrome where concomitant repair of the cardiac defect was carried out. One 12 year old patient received the right upper lobe of her mother as a total right lung transplant for bronchopulmonary dysplasia.
authors.affiliation: Stanford University, School of Medicine, California 94305.
authors.forename: N E
authors.initials: NE
authors.lastname: Shumway
mesh_terms: D002140:California; D002641:Chicago; D002985:Clinical Protocols; D003524:Cyclosporins / Q000627:therapeutic use; D004739:England; D016027:Heart Transplantation / Q000266:history* / Q000379:methods / Q000401:mortality; D006354:Heart, Artificial / Q000266:history; D016041:Heart-Lung Transplantation / Q000266:history* / Q000379:methods / Q000401:mortality; D049673:History, 20th Century; D006801:Humans; D015996:Survival Rate
chemical_list: D003524:Cyclosporins